Arvinas (ARVN) EBITDA Margin Growth (3y) (2020 - 2026)
Arvinas (ARVN) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-14,779.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-14,779.00 |
| Dec 31, 2025 |
-50,735.00 |
| Sep 30, 2025 |
12,502.00 |
| Jun 30, 2025 |
-5,858.00 |
| Mar 31, 2025 |
33,663.00 |
| Dec 31, 2024 |
9,027.00 |
| Sep 30, 2024 |
46,397.00 |
| Jun 30, 2024 |
87,295.00 |
| Mar 31, 2024 |
48,055.00 |
| Dec 31, 2023 |
96,497.00 |
| Sep 30, 2023 |
24,161.00 |
| Jun 30, 2023 |
33,931.00 |
| Mar 31, 2023 |
14,352.00 |
| Dec 31, 2022 |
26,151.00 |
| Sep 30, 2022 |
-22,615.00 |
| Jun 30, 2022 |
24,187.00 |
| Mar 31, 2022 |
10,129.00 |
| Dec 31, 2021 |
32,084.00 |
| Sep 30, 2021 |
-8,778.00 |
| Jun 30, 2021 |
-66,766.00 |
